1. Home
  2. AMPH vs ETON Comparison

AMPH vs ETON Comparison

Compare AMPH & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$21.02

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$33.98

Market Cap

872.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
ETON
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.8M
872.7M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
AMPH
ETON
Price
$21.02
$33.98
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$28.38
$39.33
AVG Volume (30 Days)
614.0K
334.0K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
0.05
Revenue
$719,887,000.00
$79,950,000.00
Revenue This Year
$6.90
$40.90
Revenue Next Year
$4.64
$47.23
P/E Ratio
$139.50
$669.80
Revenue Growth
N/A
104.94
52 Week Low
$16.65
$13.31
52 Week High
$31.26
$35.66

Technical Indicators

Market Signals
Indicator
AMPH
ETON
Relative Strength Index (RSI) 58.80 64.75
Support Level $18.92 $15.77
Resistance Level $24.61 $35.66
Average True Range (ATR) 0.83 1.64
MACD 0.11 0.18
Stochastic Oscillator 98.15 84.84

Price Performance

Historical Comparison
AMPH
ETON

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: